Researchers at The Institute of Cancer Research in the UK have published research which could transform their understanding of prostate cancer and its future treatment.
In a new study, scientists used Big Data analytical techniques to identify 80 new molecular weaknesses in prostate cancer that could be targeted by existing drugs, some of them already licensed for use in the UK or being used in clinical trials. It is thought that this offers promise for further study into new approaches to treatment.
The new discoveries greatly improve researchers’ understanding of prostate cancer and how they might treat it, bringing hope for men and their families who are affected by the disease.
Read more on the Institute of Cancer Research website.